Table 3 Percentage of improvement in the RSS-m, oesophagus manometry and nailfold capillaroscopy considering evaluation at baseline and immediately following intervention
From: Lidocaine for systemic sclerosis: a double-blind randomized clinical trial
Placebo group, n % | Lidocaine group, n % | P-value | |
|---|---|---|---|
Improvement (decrease) in the RSS-m by at least 30% | |||
Yes | 8 (66.7%) | 6 (50%) | 0.408* |
No | 4 (33.3%) | 6 (50%) | |
Improvement (increase) in lower oesophageal sphincter pressure by at least 30% | |||
Yes | 3 (25%) | 6 (50%) | 0.206* |
No | 9 (75%) | 6 (50%) | |
Improvement (increase) in the amplitude of peristaltic waves by at least 30% | |||
Yes | 2 (16.7%) | 4 (33.3%) | 0.346* |
No | 10 (82.3%) | 8 (66.7%) | |
Improvement (reduction) in the number of enlarged loops by at least 30% | |||
Yes | 2 (16.7%) | 4 (33.3%) | 0.346* |
No | 10 (83.3%) | 8 (66.7%) | |
Improvement (reduction) in capillary avascular areas by at least 30% | |||
Yes | 2 (16.7%) | 2 (16.7%) | 1.00* |
No | 10 (83.3%) | 10 (83.3%) |